Trials / Sponsors / NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, T Alzheimer Disease | Phase 2 | 2023-11-19 |
| Completed | A Multiple-Dose PK Study to Evaluate the Comparative Bioavailability of PrimeC Tablets to Ciprofloxacin Tablet Pharmacokinetics | Phase 1 | 2022-07-26 |
| Completed | A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension Amyotrophic Lateral Sclerosis, ALS | Phase 2 | 2022-05-31 |
| Completed | A Pilot Study to Evaluate the PK Profile of PrimeC-ER Tablets in Healthy Adult Subjects Pharmacokinetics | Phase 1 | 2022-04-08 |
| Completed | Ciprofloxacin/Celecoxib Combination in Patients With ALS ALS (Amyotrophic Lateral Sclerosis) | Phase 1 | 2019-12-09 |
| Completed | Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS Amyotrophic Lateral Sclerosis, ALS | Phase 2 | 2019-11-25 |